Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection

There is a continuous effort to develop efficient treatments for coronavirus disease 2019 (COVID-19) and other viral respiratory diseases. Among the different strategies, inhaled treatment is considered one of the most logical and efficient approaches to treating COVID-19, as the causative “SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Tushar, Sinha, Shubhra, Harfoot, Rhodri, Quiñones-Mateu, Miguel E., Das, Shyamal C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535576/
https://www.ncbi.nlm.nih.gov/pubmed/37765198
http://dx.doi.org/10.3390/pharmaceutics15092229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535576/
https://www.ncbi.nlm.nih.gov/pubmed/37765198
http://dx.doi.org/10.3390/pharmaceutics15092229

Ejemplares similares